An 80-year-old man with suspected recurrent prostate carcinoma underwent Ga-PSMA PET/CT, which showed enlarged axillary lymph nodes with intensely increased Ga-PSMA uptake, an atypical site for prostate cancer metastasis. Fine-needle aspiration biopsy revealed metastatic malignant melanoma. FDG PET/CT revealed congruent intense FDG uptake. Therefore, malignant melanoma should be included in the list of malignancies that can be seen positive on Ga-PSMA PET/CT. In unclear Ga-PSMA PET-positive lesions, further clarification with other imaging techniques or biopsy is mandatory to avoid scan misinterpretation. Review of the literature revealed other non-prostate cancer causes of elevated PSMA uptake classified into neoplastic and nonneoplastic conditions.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Clinical nuclear medicine. 2017 Dec 30 [Epub ahead of print]
Reut Anconina, Nir Hod, Daniel Levin, Dina Ezroh Kazap, Sophie Lantsberg
From the Institute of Nuclear Medicine and Molecular Imaging, Soroka University Medical Center, Beer-Sheva, Israel. Affiliated to Ben Gurion University of the Negev.